Article

Gains in lung cancer

As attention moves to lung cancer this month, I wanted to share the infographic below. It highlights current research into lung cancer and shows, among other points, that lung cancer is no longer one disease. A few years ago, I was attending the annual meeting of ASCO (the professional oncology organization), which showcases studies that will change clinical practice and future research. Scientists were discussing the gains a new treatment had made in that it targets about 10 percent of non-small cell lung cancers. While some people questioned the importance of a treatment that only works in a small group of patients, the researchers were quick to note that 10 percent of patients diagnosed with lung cancer in a year is still more people affected than all those diagnosed with Hodgkin lymphoma in a year (actually, it's more than double). It's the number one cancer killer and a stigma of blame has hindered awareness and research funding. Add to that the absolute complexity of the disease, and it makes for a tough cancer to crack. Fortunately, research is beginning to make small gains in this hard-to-treat cancer. Advocacy organizations are increasing awareness and funding. Lung cancer survivors are raising their voices to help remove the stigma of the disease.We have a long way to go, but I'm confident we're on the right track.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Image of woman with brown hair.
Image of man with black hair.
Image of bald man.
Image of man.
Related Content